news

Our latest
Press Releases & Updates

Latest press releases

RetinAI OCT Atlas® is now CE-marked for Clinical Use: one algorithm for AMD, DR, DME, and Glaucoma

RetinAI OCT Atlas® is now CE-marked under EU MDR 2017/745 for clinical use across AMD, Diabetic Retinopathy, DME, and Glaucoma, validated in the DILL study across 124 patients and three OCT devices.

RetinAI & OptymEdge Collaborate to Accelerate Ophthalmic Drug Development Through AI-Powered Reading Center Solutions

EarlySight announces strategic collaboration with RetinAI to enhance clinical Insights from its Cellularis® Retinal Imaging Platform

EarlySight and Ikerian (RetinAI) have announced a new collaboration to integrate EarlySight’s Cellularis® imaging technology with RetinAI’s AI-driven Discovery® platform. Together, the companies aim to enhance retinal imaging and analysis for clinical and research use.

EssilorLuxottica acquires RetinAI, accelerating transformative AI and data-powered eye health solutions

EssilorLuxottica has acquired Ikerian AG, the parent company of RetinAI, strengthening its med-tech strategy with advanced AI and data-driven solutions that enhance clinical workflows and improve patient care in ophthalmology.

Latest updates

124E International Congress de la SFO [MAY'18]

RetinAI had the pleasure to present in the 124e Congrès International de la Société Française d'Ophthalmologie in the session: 'L'impact de l'intelligence artificielle dans la santé visuelle', organised by Optic 2000 in Paris! Wonderful day presenting how AI and machine learning are changing the current paradigm of screening and monitoring of eye diseases.

ARVO 2018 Honolulu - Hawaï [APRIL-MAY'18]

RetinAI is getting ready for the American Research in Vision and Ophthalmology #ARVO2018 in Hawaii! Come to our booth 1039 if you want to learn about how #AI is changing the world of ophthalmic care!

Bilan Magazine TOP 50 Startups in which to invest 2018 [FEBRUARY'18]

RetinAI has been selected as one of the TOP50 Swiss startups in which to invest by the Bilan Magazine. The committee of experts evaluated the progress and projection of hundreds of startups from the Swiss ecosystem and selected the 50 most promising technologies for 2018! Congratulations to the team for this great success.

Read more

Venture Kick Phase III [DECEMBER'17]

Early detection of eye diseases is key for effective treatment to reduce the onset of blindness. However, the patient’s journey to diagnosis is often long and involves many challenges. Venture Kick just awarded RetinAI with 130'000.- CHF to make eye care accessible and affordable to everyone via artificial intelligence.

Read more

Contact us for more informations! We are happy to hear from you!